Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CC-115 by Bristol-Myers Squibb for Glioblastoma Multiforme (GBM): Likelihood of Approval
CC-115 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
Data Insights
CC-115 by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
CC-115 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor. According to GlobalData, Phase...